China Universal Asset Management Company’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $230K | Sell |
27,135
-413
| -1% | -$3.5K | 0.02% | 297 |
|
2025
Q1 | $221K | Sell |
27,548
-2,811
| -9% | -$22.6K | 0.02% | 304 |
|
2024
Q4 | $273K | Buy |
30,359
+2,857
| +10% | +$25.7K | 0.03% | 304 |
|
2024
Q3 | $202K | Buy |
27,502
+10,700
| +64% | +$78.4K | 0.02% | 299 |
|
2024
Q2 | $95.9K | Sell |
16,802
-11,000
| -40% | -$62.8K | 0.01% | 304 |
|
2024
Q1 | $139K | Buy |
27,802
+11,189
| +67% | +$56.1K | 0.02% | 337 |
|
2023
Q4 | $149K | Buy |
16,613
+12,940
| +352% | +$116K | 0.03% | 239 |
|
2023
Q3 | $28.5K | Buy |
3,673
+1,798
| +96% | +$14K | 0.01% | 272 |
|
2023
Q2 | $18.2K | Sell |
1,875
-57
| -3% | -$552 | 0.01% | 276 |
|
2023
Q1 | $21.2K | Buy |
1,932
+488
| +34% | +$5.35K | 0.01% | 214 |
|
2022
Q4 | $6.24K | Buy |
1,444
+116
| +9% | +$501 | ﹤0.01% | 271 |
|
2022
Q3 | $10K | Buy |
+1,328
| New | +$10K | ﹤0.01% | 203 |
|